Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -212.01%-3.82B | ---- | 77.52%-1.23B | ---- | -241.31%-5.45B | ---- | 81.39%3.86B | ---- | -19.49%2.13B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | 93.96%-27.85M | ---- | 18.41%-460.82M | ---- | -113.06%-564.8M |
| Impairment and provisions: | ---- | 2,387.19%2.83B | ---- | -96.09%113.75M | ---- | 38,937.88%2.91B | ---- | -72.73%7.45M | ---- | 82.09%27.31M |
| -Impairment of property, plant and equipment (reversal) | ---- | -79.37%43.36M | ---- | --210.18M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --22.55M |
| -Other impairments and provisions | ---- | 2,988.62%2.79B | ---- | -103.32%-96.44M | ---- | 38,937.88%2.91B | ---- | 56.44%7.45M | ---- | -68.26%4.76M |
| Revaluation surplus: | ---- | -64.01%121.96M | ---- | -5.18%338.86M | ---- | 242.44%357.38M | ---- | -9,527.97%-250.91M | ---- | 97.93%-2.61M |
| -Fair value of investment properties (increase) | ---- | -64.00%121.98M | ---- | -5.18%338.86M | ---- | 737.62%357.38M | ---- | -2,050.77%-56.05M | ---- | 97.93%-2.61M |
| -Other fair value changes | ---- | ---25K | ---- | ---- | ---- | ---- | ---- | ---194.86M | ---- | ---- |
| Asset sale loss (gain): | ---- | 13.05%144.06M | ---- | -81.48%127.43M | ---- | 721.41%688.06M | ---- | -2,329.66%-110.73M | ---- | 104.25%4.97M |
| -Loss (gain) from sale of subsidiary company | ---- | 13.46%145.8M | ---- | -79.65%128.5M | ---- | 2,149.70%631.51M | ---- | -685.07%-30.81M | ---- | 104.31%5.27M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -63.21%-1.75M | ---- | 41.32%-1.07M | ---- | -123.11%-1.83M | ---- | -172.67%-818K | ---- | -105.56%-300K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 173.80%58.37M | ---- | ---79.1M | ---- | ---- |
| Depreciation and amortization: | ---- | -35.79%57.27M | ---- | -6.59%89.19M | ---- | 57.22%95.49M | ---- | 87.63%60.74M | ---- | 42.36%32.37M |
| -Amortization of intangible assets | ---- | -12.05%9.98M | ---- | 0.00%11.35M | ---- | 0.01%11.35M | ---- | 51.68%11.35M | ---- | 100.03%7.48M |
| Financial expense | ---- | 60.89%262.21M | ---- | 152.68%162.98M | ---- | 231.13%64.5M | ---- | -17.90%19.48M | ---- | 18.74%23.73M |
| Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 143.01%20.69M | ---- | -253.57%-48.1M |
| Special items | ---- | 120.28%14.79M | ---- | -7.16%-72.93M | ---- | 80.98%-68.06M | ---- | -30.39%-357.74M | ---- | -40.15%-274.36M |
| Operating profit before the change of operating capital | ---- | 15.62%-393.03M | ---- | 67.50%-465.81M | ---- | -151.46%-1.43B | ---- | 110.22%2.79B | ---- | -34.62%1.32B |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | ---- | 443.72%6.21B | ---- | -86.09%1.14B | ---- | 1,221.45%8.21B | ---- | 90.57%-732.4M | ---- | -5.68%-7.77B |
| Accounts receivable (increase)decrease | ---- | 84.69%-177.37M | ---- | 38.81%-1.16B | ---- | -195.34%-1.89B | ---- | -176.70%-640.9M | ---- | -53.52%835.57M |
| Accounts payable increase (decrease) | ---- | -119.37%-188.04M | ---- | -34.35%970.9M | ---- | 143.44%1.48B | ---- | 938.34%607.54M | ---- | -56.62%58.51M |
| Special items for working capital changes | ---- | -1,025.44%-6.63B | ---- | 117.98%716.07M | ---- | -767.96%-3.98B | ---- | -88.88%596.11M | ---- | -13.10%5.36B |
| Cash from business operations | 81.60%-58.09M | -197.45%-1.17B | -122.67%-315.68M | -49.46%1.21B | 565.50%1.39B | -8.82%2.38B | -111.21%-299.14M | 1,499.04%2.62B | 3,144.98%2.67B | -106.73%-186.94M |
| Other taxs | 115.42%14.86M | 521.69%595.86M | 56.08%-96.33M | 93.87%-141.3M | 46.06%-219.33M | -75.38%-2.3B | 60.34%-406.59M | -30.38%-1.31B | -55.97%-1.03B | -23.08%-1.01B |
| Net cash from operations | 89.51%-43.24M | -154.39%-578.65M | -135.12%-412.01M | 1,208.38%1.06B | 266.24%1.17B | -93.75%81.32M | -142.94%-705.73M | 209.02%1.3B | 320.59%1.64B | -160.93%-1.19B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -67.89%1.19M | -81.94%5.69M | -77.66%3.7M | -88.51%31.52M | -56.07%16.56M | 93.56%274.41M | -16.75%37.69M | 5.81%141.77M | 20.62%45.28M | 105.39%133.99M |
| Dividend received - investment | -64.81%581K | 687.67%2.36M | --1.65M | -99.46%300K | ---- | 9,050.98%56M | -3.27%592K | --612K | --612K | ---- |
| Loan receivable (increase) decrease | -97.95%1.3M | 118.02%79.75M | 119.54%63.48M | -273.54%-442.68M | -245.99%-324.91M | 115.39%255.09M | 110.61%222.55M | -53.44%-1.66B | -1,615.43%-2.1B | 59.60%-1.08B |
| Sale of fixed assets | 529.34%3.63M | -58.65%2M | 1.95%576K | -70.60%4.83M | -77.83%565K | 542.99%16.41M | -42.52%2.55M | 123.66%2.55M | 619.64%4.43M | -76.43%1.14M |
| Purchase of fixed assets | -1,287.62%-4.48M | 56.28%-13.52M | 91.73%-323K | -81.41%-30.92M | 58.78%-3.91M | 66.99%-17.04M | 57.40%-9.48M | -5.04%-51.62M | -30.34%-22.25M | -9.87%-49.15M |
| Purchase of intangible assets | ---- | ---- | ---110K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | -102.52%-235K | 299.30%431.45M | 104.63%9.31M | 123.64%108.05M | -539.93%-201.04M | -417.87%-456.99M | 119.56%45.7M | -17.99%143.77M | -403.39%-233.66M | 41.77%175.29M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | 125.84%17.46M | ---- | 90.09%-67.54M | -110.44%-18.57M | -380.83%-681.56M |
| Recovery of cash from investments | --3.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | --4.28M | 98.78%-9.34M | ---- | -101,018.01%-763.44M | ---- | 99.87%-755K | 99.93%-245K | -65.89%-567.49M | -8,275.33%-335.01M | -79.86%-342.08M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---16.12M | ---324.53M | ---- | ---- | ---- |
| Net cash from investment operations | -87.83%9.53M | 145.63%498.39M | 115.27%78.29M | -950.40%-1.09B | -1,937.24%-512.73M | 106.25%128.45M | 99.05%-25.17M | -11.56%-2.06B | -747.51%-2.66B | 25.47%-1.84B |
| Net cash before financing | 89.90%-33.71M | -182.89%-80.25M | -150.53%-333.72M | -113.52%-28.37M | 190.36%660.46M | 127.83%209.77M | 27.91%-730.9M | 75.18%-753.63M | -203.02%-1.01B | -492.86%-3.04B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -99.34%5.91M | 17.47%869.11M | 221.87%895.11M | -78.73%739.89M | -92.02%278.1M | -71.64%3.48B | -51.31%3.48B | 22.24%12.26B | 16.43%7.15B | 4.57%10.03B |
| Refund | 89.03%-35.31M | 59.87%-415.15M | 18.32%-322.02M | 84.44%-1.03B | 91.69%-394.23M | 27.65%-6.65B | -1.82%-4.74B | -30.28%-9.19B | -6.45%-4.66B | -18.86%-7.05B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | -97.78%68.76M | ---- | -50.39%3.09B | 88.09%1.93B | 15.98%6.23B |
| Interest paid - financing | 76.03%-18.68M | ---- | 74.57%-77.92M | 79.43%-318.24M | 47.82%-306.39M | 22.07%-1.55B | 28.86%-587.21M | -17.64%-1.99B | 9.29%-825.48M | -30.91%-1.69B |
| Dividends paid - financing | -0.79%-6.28M | 64.30%-66.05M | 93.95%-6.23M | -833.66%-184.99M | -208.09%-102.92M | 90.97%-19.81M | 23.40%-33.41M | -54.53%-219.38M | -82.95%-43.61M | 22.86%-141.97M |
| Absorb investment income | ---- | ---- | ---- | -99.00%40K | ---- | -99.38%4M | 143.13%217.81M | -28.20%650.21M | 90.64%89.58M | 101.96%905.64M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 99.93%-666K | ---- | 71.59%-888.27M | 12.43%-872.81M | 48.16%-3.13B | 62.06%-996.74M | -183.07%-6.03B |
| Other items of the financing business | 86.97%-71.86M | -205.28%-630.24M | 3.85%-551.37M | 12.64%-206.45M | 61.63%-573.45M | 92.15%-236.33M | -46,637.68%-1.49B | -475.39%-3.01B | -90.15%3.21M | -2,647.14%-523.31M |
| Net cash from financing operations | -102.17%-126.22M | 75.89%-242.32M | 94.32%-62.43M | 82.64%-1B | 72.74%-1.1B | -279.32%-5.79B | -252.04%-4.03B | -188.13%-1.53B | 485.04%2.65B | -70.64%1.73B |
| Effect of rate | 193.20%142.66M | -92.73%-136.82M | -30.78%-153.07M | -22.00%-70.99M | -177.74%-117.05M | -135.35%-58.19M | 1,787.79%150.55M | 217.81%164.61M | -44.44%7.98M | -566.94%-139.73M |
| Net Cash | 59.63%-159.92M | 68.78%-322.57M | 9.64%-396.15M | 81.48%-1.03B | 90.79%-438.42M | -144.73%-5.58B | -390.85%-4.76B | -74.68%-2.28B | 260.02%1.64B | -124.23%-1.31B |
| Begining period cash | -57.98%332.87M | -58.22%792.26M | -58.22%792.26M | -74.83%1.9B | -74.83%1.9B | -21.92%7.53B | -21.92%7.53B | -13.02%9.65B | -13.02%9.65B | 95.36%11.09B |
| Cash at the end | 29.86%315.61M | -57.98%332.87M | -81.88%243.05M | -58.22%792.26M | -54.12%1.34B | -74.83%1.9B | -74.12%2.92B | -21.92%7.53B | 11.99%11.29B | -13.02%9.65B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.